跳至主要内容
临床试验/PACTR202202641392530
PACTR202202641392530尚未招募3 期

Comparison of the efficacy of oral Dydrogesterone with Micronized vaginal progesterone for luteal phase support in women undergoing In vitro fertilization (IVF) at the Federal Medical Centre Abuja: a randomized clinical trial

Researcher0 个研究点目标入组 300 人开始时间: 2022年1月6日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • Signed informed consent
  • Premenopausal females, age = 19 years = 44 years
  • Non-smokers
  • Normal follicular phase (Day 2-4) hormones (FSH, LH, E2, PRL, T, and TSH
  • Documented history of infertility
  • Normal endovaginal ultrasound at screening
  • Subject is not pregnant
  • Clinically indicated protocol for induction of IVF with a fresh embryo
  • Single or dual embryo transfer
  • BMI = 18 and = 30 kg/m2

排除标准

  • Evidence of diseases which could limit participation in or completion of the study
  • Acute urogenital disease
  • Known allergic reactions to progestogens
  • Intake of any other experimental drug or on going treatment of any illness
  • participation in any other clinical trial within 30 days prior to study start
  • Disability or any condition leading to lack of fitness to participate in or to complete the study
  • Current or recent substance abuse, including alcohol and tobacco
  • History of chemotherapy or radiotherapy
  • Patients with more than 3 unsuccessful IVF attempts
  • Women in whom pregnancy is contraindicated
  • Refusal or inability to comply with the requirements of the study protocol for any reason
  • History of recurrent pregnancy loss

研究者

发起方
Researcher

相似试验